Craft

Phibro Animal Health

Stock Price

$23.5

2024-10-29

Market Capitalization

$951.8 M

2024-10-29

Revenue

$1.3 B

FY, 2025

Phibro Animal Health Summary

Company Summary

Overview
Phibro Animal Health is an animal health and mineral nutrition company. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterials, anticoccidials, nutritional specialty products, and vaccines. The Mineral Nutrition segment provides formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and other compounds. The Performance Products segment offers specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries.
Type
Public
Status
Active
Founded
1946
HQ
Teaneck, NJ, US | view all locations
Website
https://www.pahc.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jack C. Bendheim

    Jack C. Bendheim, Chairman of the Board of Directors, President, Chief Executive Officer

  • Larry L. Miller

    Larry L. Miller, Chief Operating Officer

  • Judith A. Weinstein

    Judith A. Weinstein, Senior Vice President, General Counsel and Corporate Secretary

  • Rob Aukerman

    Rob Aukerman, President, North America Region

Operating MetricsView all

Customers

3K
3.4%

FY, 2016

LocationsView all

18 locations detected

  • Teaneck, NJ HQ

    United States

    Glenpointe Centre East, 3rd Floor 300 Frank W. Burr Boulevard, Suite 21

  • Area de Promoción El Triángulo, Provincia de Buenos Aires

    Argentina

    Rutherford 4503

  • Bella Vista, NSW

    Australia

    Suite 416/14 Lexington Dr

  • Wavre, Région Wallonne

    Belgium

    Chem. du Stocquoy 3

  • Santa Cruz de la Sierra, Departamento de Santa Cruz

    Bolivia (Plurinational State of)

    Av. La salle 3035

  • Bragança Paulista, SP

    Brazil

    R. Prof. Gilberto Venturine, 555 - Cidade Planejada III

and 12 others

Phibro Animal Health Financials

Summary Financials

Revenue (Q3, 2026)
$383.5M
Gross profit (Q3, 2026)
$125.7M
Net income (Q3, 2026)
$24.0M
Cash (Q3, 2026)
$54.9M
EBIT (Q3, 2026)
$44.7M
Enterprise value
$1.6B

Footer menu